Inhibition of p38 mitogen-activated protein kinase suppresses interleukin-1β-expression and prevents progression of cardiac hypertrophy and congestive heart failure in rats.

被引：0
|
作者：
Shimamoto, A [1 ]
Oda, T [1 ]
Kodama, H [1 ]
Shimada, M [1 ]
Kanemitsu, S [1 ]
Fujinaga, K [1 ]
Takao, M [1 ]
Onoda, K [1 ]
Shimono, T [1 ]
Tanaka, K [1 ]
Shimpo, H [1 ]
Yada, I [1 ]
机构：
[1] Mie Univ, Sch Med, Tsu, Mie 514, Japan
来源：
CIRCULATION | 2000年 / 102卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [1] The case for inhibiting p38 mitogen-activated protein kinase in heart failure
    Arabacilar, Pelin
    Marber, Michael
    FRONTIERS IN PHARMACOLOGY, 2015, 6
  • [2] p38 mitogen-activated protein kinase - A future for heart failure therapy?
    Kerkela, Risto
    Force, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (03) : 556 - 558
  • [3] Inhibition of p38 mitogen-activated protein kinase prevents inflammatory bone destruction
    Mbalaviele, Gabriel
    Anderson, Gary
    Jones, Amy
    De Ciechi, Pamela
    Settle, Steve
    Mnich, Steve
    Thiede, Mark
    Abu-Amer, Yousef
    Portanova, Joseph
    Monahan, Joseph
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (03): : 1044 - 1053
  • [4] Divergent roles for Ras and Rap in the activation of p38 mitogen-activated protein kinase by interleukin-1
    Palsson, EM
    Popoff, M
    Thelestam, M
    O'Neill, LAJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (11) : 7818 - 7825
  • [5] Role of p38 mitogen-activated protein kinase in LPS/galactosamine-induced hepatic failure in rats.
    Mitsui, H
    Maruyama, T
    Maekawa, H
    Hirayama, M
    Sawatari, T
    Kimura, S
    Hashimoto, N
    HEPATOLOGY, 2000, 32 (04) : 312A - 312A
  • [6] Role of p38 mitogen-activated protein kinase in cardiac remodelling
    Frantz, S.
    Behr, T.
    Hu, K.
    Fraccarollo, D.
    Strotmann, J.
    Goldberg, E.
    Ertl, G.
    Angermann, C. E.
    Bauersachs, J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (02) : 130 - 135
  • [7] The p38 mitogen-activated protein kinase pathway-A potential target for intervention in infarction, hypertrophy, and heart failure
    Marber, Michael S.
    Rose, Beth
    Wang, Yibin
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 485 - 490
  • [8] Sustained activation of cardiac p38 mitogen activated protein kinase in the development of heart failure: Premature mortality is abolished by chronic p38 inhibition in rat model of cardiac hypertrophy and failure
    Behr, TM
    Nerurkar, SS
    Nelson, AH
    Lee, JC
    Sisko, J
    Sackner-Bernstein, JD
    Willette, RN
    CIRCULATION, 2000, 102 (18) : 289 - 289
  • [9] Inhibition of P38 mitogen-activated protein kinase protects the heart against cardiac remodeling in mice with heart failure due to myocardial infarction
    Liu, YH
    Wang, DH
    Rhaleb, NE
    Yang, XP
    Xu, JA
    Yu, AL
    Rudolph, AE
    Carretero, OA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 180A - 180A
  • [10] Inhibition of p38 mitogen-activated protein kinase prevents endothelial dysfunction in chronic heart failure: role of vascular superoxide anion production
    Widder, J
    Behr, TM
    Hu, K
    Berova, M
    Angermann, CE
    Ertl, G
    Bauersachs, J
    EUROPEAN HEART JOURNAL, 2003, 24 : 213 - 213
12345